{"url_path":"/sec/mpt/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1287865/0001193125-26-214700-index.html","accession_number":"0001193125-26-214700","cik":"0001287865","ticker":"MPT","issuer_name":"MEDICAL PROPERTIES TRUST INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1287865/0001193125-26-214700-index.html","primary_entity_key":"0001287865","primary_entity_name":"MEDICAL PROPERTIES TRUST INC"},"word_count":67,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\n(a)\nNone.\n\n(b)\nNone.\n\n(c)\nDirector and Officer Trading Arrangements\n\n38\n\n \n\nDuring the three months ended March 31, 2026, none of the Company's directors or officers (as defined in Rule 16a-1(f) of the Securities and Exchange Act) adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).\n\n39"}